Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country. A randomized control trial

Diabetes Research and Clinical Practice

Volumn 107, Issue 2, 2015, Pages 290-299

  Ainuddin, Jahanara ^a   Karim, Nasim ^b   Hasan, Anjum Ara ^c   Naqvi, Sanower Ali ^c  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b BAHRIA UNIVERSITY   (Pakistan)

^c HAMDARD UNIVERSITY   (Pakistan)

Author keywords

Gestational diabetes; Insulin; Metformin; Pregnancy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; METFORMIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG COST; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL WEIGHT GAIN; MEDICATION COMPLIANCE; MONOTHERAPY; MORNING DOSAGE; NEONATAL HYPOGLYCEMIA; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; OPEN STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN; BLOOD; DIABETES, GESTATIONAL; DRUG COMBINATION; INCIDENCE; METABOLISM; PAKISTAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; DEVELOPING COUNTRIES; DIABETES, GESTATIONAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; METFORMIN; PAKISTAN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84922058729     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.10.001     Document Type: Article

References (35)

1. American Diabetes Association Gestational diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S103-S105.
2. Beischer N.A., Oats J.N., Henry O.A., Sheedy M.T. Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia. Diabetes 1991, 40(Suppl. 2):35-38.
3. Shera A.S., Jawad F., Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract 2007, 70(2):219-222.
4. Jawad F., Irshaduddin P. Prevelance of GDM and pregnancy outcome in Pakistan. East Mediterr Health J 1996, 2(2):268-273.
5. Crowther C.A., Hiller J.E., Moss J.R. Effect of treatment of gestational mellitus on pregnancy outcomes. N Engl J Med 2005, 352:2477-2486.
6. Voillet Benoit, Gulgas Bruno, Garcia N.S., Leclarc J., Mforetz F. Andreilli cellular and molecular mechanisms of metformin and overview. Clin Sci 2012, 122(6):253-270.
7. Casallero A.E., Delgado A., Aguilar-Salinas C.A., Herrera A.N., Castello J.L., Labrera T., et al. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo controlled, randomized clinical trial. J Clin Endocrinol Metab 2004, 89:3943-3948.
8. Hundal R.S., Inzucchi S.E. Metformin new understanding new uses. Drug 2003, 63:1879-1894.
9. Ellioti B.D., Langer O., Schussling B.A. Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin. Am J Obstet Gynecol 1997, 176:527-530.
10. Glueck C.J., Philips H., Cameron D. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first trimester spontaneous abortion: a pilot study. Fertil Steril 2001, 75:46-52.
11. Jakubowicz D.J., Iuorno M.J., Jakubowicz S. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:524-529.
12. Haq F., Rizvi J. continuation of metformin reduces early pregnancy loss in obese Pakistani women with PCOS. Gynecol Obstet Invest 2010, 69:184-189.
13. Briggs G., Freman R., Faffe S. Drugs in pregnancy and lactation 2005, 1017-1020. Lippincott, Philadelphia. seventh ed.
14. Coetzee E.J., Jackson W.P. Pregnancy in established non-insulin dependent diabetes. A five and a half year study at Groote Schuur Hospital. S Afr Med J 1980, 58:795-802.
15. Hughes R.C.E., Rowan J.A. Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome. Diabetic Med 2006, 23:318-322. (Diabetes UK).
16. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diabetes Res Clin Pract 2014, 103(2):137-149.
17. Rowan J.A., Hogue W.M., Gao W. Metformin versus insulin for the treatment of gestational diabetes. N Eng J Med 2008, 19(358):2003-2015.
18. Rai L., Meenakshi D., Asha.K. Metformin-a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian J Med Sci 2009, 63(11):491-497.
19. Mathur R. Insulin resistance and the use of metformin: effect on body weight. Bariatric Times 2011, 8(1):10-12.
20. Basit A., Shera A.S. Prevalence of metabolic syndrome in Pakistan. Metab Syndr Relat Disord 2008, 6:171-175.
21. Hyer L., Balani J., Johson A. Metformin treatment for gestational diabetes. Br J Diabetes Vasc Dis 2009, 9:220-225.
22. Moore L.E., Brieny G.I., Clokey D. Metformin and insulin in the management of gestational diabetes mellitus. J Reprod Med 2007, 52:1011-1015.
23. Tertti K., Ekblad U., Terovahlberg Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case control study. Rev Diabet Stud 2008, 5:95-101.
24. Balani J., Hyer L., Rodin D.A. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case control study. Diabetes Med 2009, 26:798-802.
25. Hellmuth E., Damm P., Pedersen L.M. Oral hypoglycemic agents in 118 diabetic pregnancies. Diabetes Med 2000, 17:507-511.
26. Kaaja R., Tikkanen M.J., Vllnikka L. Serum lipoproteins, insulin and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995, 85:353-356.
27. Sirtori C.R., Pasik C. Re-evaluation of a biguanide, metformin mechanism of action and tolerability. Pharmacol Res 1994, 30:187-228.
28. Goh J.E.L., Sadler L., Rowan J.A. Metformin for gestational diabetes in routine clinical practice. Diabetic Med 2011, 28(9):1082-1087.
29. Ijas H., Vaarasmaki M., Morinpaunen L. Metformin should be considered in the treatment of gestational diabetes: a prospective randomized study. BJOG 2010, 10.1111/j.1471-0528-2010.
30. Renda E., Faraci M., Prima F., Valeuti O., Hyseni E., Moate S., et al. Treatment of gestational diabetes: oral hypoglycemic agents or insulin?. J Perinat Med 2011, 5(3):63-64.
31. Niromanesh S., Alan A., Sharbaf F.R., Amjadi N., Moosavi S., Akbari S. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res Clin Pract 2012, 98(3):422-429.
32. Nicholson W., Bolen S., Witkop C.T. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes. Obstet Gynecol 2009, 113(1):193-205.
33. Dulkotia J.S., Ola, Bolarinde, Fraser R. Oral hypoglycemic agents vs. insulin in management of gestational diabetes: a systematic review and metaanalysis. AJOG 2010, 9:457-459.
34. Maymone A.C., Baillargeon J.P., Menard J., Ardilouze J.C. Oral hypoglycemic agents for gestational diabetes mellitus?. Expert Opin Drug Saf 2011, 10(2):227-238.
35. Thung N.W. The management of gestational diabetes. Vasc Health Risk Manage 2009, 5:153-164.